Once tumors reached a palpable size, adeno-associated virus (AAV)/ESRP1 or AAV/Null was injected intratumorally, and AAV/ESRP1 significantly inhibited RCC tumor growth in mouse models (Fig. 2H-K). Here, ESRP1 is linked to renal cell carcinoma.